COVID-19 cases are very high across Europe. Current measures are not reducing virus
spread sufficiently, and new severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

All viruses mutate. But three variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have raised particular concerns. On Jan 21, 2021, the UK New and …

The current vaccination campaign against SARS-CoV-2 has many challenging aspects, one
of which is maintaining the cold chain for the distribution, delivery, and storage of available …

Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and
clinical outcomes - The Lancet Infectious Diseases Skip to Main Content Advertisement The …

As focus in the SARS-CoV-2 pandemic shifts to the emergence of new variants of concern
(VOC), characterising the differences between new variants and non-VOC lineages will …

Vaccinating against SARS-CoV-2 Early in the spread of SARS-CoV-2, the virus mutated,
and the mutant form is now the most prevalent genotype worldwide. The vaccines currently …

Science has uncovered much about SARS-CoV-2 and made extraordinary and
unprecedented progress on the development of COVID-19 vaccines, but there is still great …

In September, 2020, the WHO Prioritisation Roadmap for COVID-19 vaccines gave priority to
prevention of severe disease and the highest risk groups. In July, 2021, the revised …

Immune-escape variants have raised concerns about the effectiveness of vaccines as the
world scales up SARS-CoV-2 immunisation. COVID-19 vaccines have shown up to 95 …

Abstract Background The SARS-CoV-2 coronavirus epidemic is hastening the discovery of
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …